MINI FUTURE OPTIONSSCHEIN - BOSTON SCIENTIFIC | Market Closed - Börse Stuttgart 15:48:18 2024-05-22 EDT | ||
| 1.89 EUR | +2.72% |
|
| Current month | -15.25% | ||
| 1 month | -27.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 1.89 | +2.72% |
| 24-05-21 | 1.84 | -2.65% |
| 24-05-20 | 1.89 | -4.06% |
| 24-05-17 | 1.97 | +1.03% |
| 24-05-16 | 1.95 | -0.51% |
Delayed Quote Börse Stuttgart
Last update May 22, 2024 at 03:48 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JB9506 |
| ISIN | DE000JB95063 |
| Date issued | 2024-01-03 |
| Strike | 95.67 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.41 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.47 € |
|---|---|
| Lowest since issue | 1.83 € |
| Spread | 0.01 € |
| Spread % | 0.52% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
75.37
USD
Average target price
81.4
USD
Spread / Average Target
+8.00%
- Stock Market
- Certificates
- Certificat
